Benzinga | Aug 11, 2021 04:13PM EDT

Histogen Q2 EPS $(0.10) Beats $(0.17) Estimate, Sales $5.00K Down From $108.00K YoY

Histogen (NASDAQ:HSTO) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.17) by 41.18 percent. This is a 93.42 percent increase over losses of $(1.52) per share from the same period last year. The company reported $5.00 thousand in sales this quarter. This is a 95.37 percent decrease over sales of $108.00 thousand the same period last year.